|
|
Home
The Word Brain
|
My Amedeo
FAQ
Privacy
About
|
|
|||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
| Bladder Cancer |
|
Free Subscription
1 Abdom Radiol (NY) |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Bladder Cancer is free of charge.
Pictorial review of the diagnosis of muscle-invasive bladder cancer using vesical
imaging-reporting and data system (VI-RADS).
Abdom Radiol (NY). 2024 Jun 20. doi: 10.1007/s00261-024-04424.
PubMed
Abstract available
Imaging and Downstaging Bladder Cancer with the (177)Lu-Labeled Bioorthogonal
Nanoprobe.
ACS Nano. 2024 Jun 21. doi: 10.1021/acsnano.4c04303.
PubMed
Abstract available
A Novel tsRNA, m(7)G-3' tiRNA Lys(TTT), Promotes Bladder Cancer Malignancy Via
Regulating ANXA2 Phosphorylation.
Adv Sci (Weinh). 2024 Jun 18:e2400115. doi: 10.1002/advs.202400115.
PubMed
Abstract available
Cepharanthine inhibits migration, invasion, and EMT of bladder cancer cells by
activating the Rap1 signaling pathway in vitro.
Am J Transl Res. 2024;16:1602-1619.
PubMed
Abstract available
Examining the Concordance of Patient Age Distribution between Genitourinary (GU)
Clinical Trials and Real-World Disease Populations: Kidney, Prostate and Bladder
Cancer Analysis.
Ann Surg Oncol. 2024 Jun 17. doi: 10.1245/s10434-024-15559.
PubMed
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repu
Bacillus Calmette-Guerin pneumonitis after intravesical instillation: Report of
two cases and a review of the literature.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2024;168:181-186.
PubMed
Abstract available
Learning curve for intracorporeal robotic Padua ileal bladder: 10-year functional
assessment from a high-volume single-centre series.
BJU Int. 2024;134:103-109.
PubMed
Abstract available
'Case of the Month' from The University of Texas MD Anderson Cancer Center,
Houston, Texas, USA: ependymoma of the urinary bladder.
BJU Int. 2024;134:45-47.
PubMed
Is there a role for pembrolizumab beyond progression in urothelial carcinoma?
BJU Int. 2024;134:43-44.
PubMed
Long-term functional outcomes after robot-assisted radical cystectomy with
intracorporeal ileal orthotopic neobladder.
BJU Int. 2024;134:48-50.
PubMed
Pembrolizumab for the treatment of bladder and renal cancer and important new
data concerning screening for prostate cancer.
BJU Int. 2024;134:4-5.
PubMed
Gemcitabine/nab-paclitaxel vs gemcitabine/carboplatin for advanced urothelial
carcinoma.
BJU Int. 2024;134:63-71.
PubMed
Abstract available
Isorhapontigenin inhibition of basal muscle-invasive bladder cancer attributed to
its downregulation of SNHG1 and DNMT3b.
BMC Cancer. 2024;24:737.
PubMed
Abstract available
Basement membrane-related MMP14 predicts poor prognosis and response to
immunotherapy in bladder cancer.
BMC Cancer. 2024;24:746.
PubMed
Abstract available
Compressed sensing 3D T2WI radiomics model: improving diagnostic performance in
muscle invasion of bladder cancer.
BMC Med Imaging. 2024;24:148.
PubMed
Abstract available
Carcinoma in situ within the bladder trigone with an isolated metastasis to the
prostate without involvement of prostatic urethra: a unique case report.
BMC Urol. 2024;24:127.
PubMed
Abstract available
Prognostic Effects of Sarcopenia on Patients with Bladder Cancer: A Systematic
Review and Meta-Analysis.
Cancer Invest. 2024 Jun 18:1-15. doi: 10.1080/07357907.2024.2363879.
PubMed
Abstract available
Real-world incidences and risk factors of immune-related adverse events in
patients treated with immune checkpoint inhibitors: A nationwide retrospective
cohort study.
Cancer Lett. 2024;596:216998.
PubMed
Abstract available
Role of Gut Microbiome in Neoadjuvant Chemotherapy Response in Urothelial
Carcinoma: A Multi-institutional Prospective Cohort Evaluation.
Cancer Res Commun. 2024;4:1505-1516.
PubMed
Abstract available
Bladder Cancer Invading the Prostate and Penis and Multiple Bone Metastases
Showing Significant Improvement after a Short-Term Pembrolizumab Therapy
following Radiation and Gemcitabine and Cisplatin Therapy Leading to a
Pathologically Complete Remissi
Case Rep Urol. 2024;2024:7525757.
PubMed
Abstract available
Distinct Infiltration of T Cell Populations in Bladder Cancer Molecular Subtypes.
Cells. 2024;13:926.
PubMed
Abstract available
Optimizing the Use of Next-Generation Sequencing Assays in Patients With
Urothelial Carcinoma: Recommendations by the 2023 San Raffaele Retreat Panel.
Clin Genitourin Cancer. 2024;22:102091.
PubMed
Abstract available
Temporal Trends and Cancer-Specific Mortality in Nonmetastatic Muscle-Invasive
Urothelial Carcinoma of the Urinary Bladder Treated With Trimodal Therapy.
Clin Genitourin Cancer. 2024;22:102119.
PubMed
Abstract available
Hydronephrosis as a Prognostic Factor in Primary Bladder Adenocarcinoma: Insights
from a 15-Year Tertiary Center Experience.
Clin Genitourin Cancer. 2024;22:102120.
PubMed
Abstract available
Digital spatial profiling of the microenvironment of muscle invasive bladder
cancer.
Commun Biol. 2024;7:737.
PubMed
Abstract available
Urachal mixed adenocarcinoma and small cell neuroendocrine carcinoma with
widespread metastasis and resistance to chemotherapy: a case report.
Diagn Pathol. 2024;19:81.
PubMed
Abstract available
Correction: Overexpressed KCNK1 regulates potassium channels affecting molecular
mechanisms and biological pathways in bladder cancer.
Eur J Med Res. 2024;29:342.
PubMed
Challenging the Paradigm of "BCG-unresponsive" Bladder Cancer: Does Additional
Bacillus Calmette-Guerin Have an Effect?
Eur Urol. 2024 Jun 14:S0302-2838(24)02409-6. doi: 10.1016/j.eururo.2024.
PubMed
Prognostic Impact and Spatial Interplay of Immune Cells in Urothelial Cancer.
Eur Urol. 2024;86:42-51.
PubMed
Abstract available
On the Road Towards Curing Advanced Bladder Cancer.
Eur Urol Focus. 2024 Jun 16:S2405-4569(24)00056.
PubMed
Abstract available
Diagnostic Test Accuracy of Urinary DNA Methylation-based Biomarkers for the
Detection of Primary and Recurrent Bladder Cancer: A Systematic Review and
Meta-analysis.
Eur Urol Focus. 2024 Jun 19:S2405-4569(24)00088.
PubMed
Abstract available
The Role of Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer:
A Systematic Review and Meta-analysis.
Eur Urol Oncol. 2024 Jun 19:S2588-9311(24)00152.
PubMed
Abstract available
GINS1 promotes the initiation and progression of bladder cancer by activating the
AKT/mTOR/c-Myc signaling pathway.
Exp Cell Res. 2024;440:114125.
PubMed
Abstract available
Aberrant cell adhesiveness due to DNA hypermethylation of KLF11 in papillary
urothelial carcinomas.
Exp Mol Pathol. 2024;137:104908.
PubMed
Abstract available
Investigating cellular similarities and differences between upper tract
urothelial carcinoma and bladder urothelial carcinoma using single-cell
sequencing.
Front Immunol. 2024;15:1298087.
PubMed
Abstract available
Mathematical model of MMC chemotherapy for non-invasive bladder cancer treatment.
Front Oncol. 2024;14:1352065.
PubMed
Abstract available
Identification of Rare EIF3E::RSPO2 Fusion in Recurrent and Aggressive Urachal
Adenocarcinoma.
Genes Chromosomes Cancer. 2024;63:e23250.
PubMed
Abstract available
CircACTR2 promotes bladder cancer progression through IKBKB-mediated NF-kappaB
signaling pathway activation.
Heliyon. 2024;10:e30778.
PubMed
Abstract available
Carcinoma arising in ileal conduit or orthotopic ileal neobladder reconstruction:
A 20-year single institute experience.
Histopathology. 2024;85:182-189.
PubMed
Abstract available
An artificial intelligence-powered PD-L1 combined positive score (CPS) analyser
in urothelial carcinoma alleviating interobserver and intersite variability.
Histopathology. 2024;85:81-91.
PubMed
Abstract available
CircZNF609 inhibited bladder cancer immunotherapy sensitivity via enhancing fatty
acid uptake through IGF2BP2/CD36 pathway.
Int Immunopharmacol. 2024;137:112485.
PubMed
Abstract available
Anti-PD-L1 antibody retains antitumour effects while mitigating
immunotherapy-related colitis in bladder cancer-bearing mice after CT-mediated
intratumoral delivery.
Int Immunopharmacol. 2024;137:112417.
PubMed
Abstract available
FGL2 as a predictive biomarker for prognosis and immunotherapy in bladder cancer.
Int J Med Sci. 2024;21:1447-1460.
PubMed
Abstract available
Exploring the DNA Methylation Profile of Genes Associated with Bladder Cancer in
Bladder Tissue of Patients with Neurogenic Lower Urinary Tract Dysfunction.
Int J Mol Sci. 2024;25:5660.
PubMed
Abstract available
LncRNA BCYRN1 as a Potential Therapeutic Target and Diagnostic Marker in Serum
Exosomes in Bladder Cancer.
Int J Mol Sci. 2024;25:5955.
PubMed
Abstract available
The value and safety of adjuvant radiotherapy (ART) after radical cystectomy in
locally advanced urothelial bladder cancer: A controlled randomized study.
Int J Radiat Oncol Biol Phys. 2024 Jun 13:S0360-3016(24)00670.
PubMed
Abstract available
A modified ureteroileal anastomosis can reduce ureteroileal anastomotic stricture
after ileal conduit.
Int Urol Nephrol. 2024;56:2235-2241.
PubMed
Abstract available
Surgeon-administered regional nerve blocks during radical cystectomy: a
feasibility study.
Int Urol Nephrol. 2024;56:2227-2234.
PubMed
Abstract available
Intravesical instillation-based mTOR-STAT3 dual targeting for bladder cancer
treatment.
J Exp Clin Cancer Res. 2024;43:170.
PubMed
Abstract available
Selecting the right treatment: Health outcome priorities in older patients with
bladder cancer.
J Geriatr Oncol. 2024;15:101811.
PubMed
Abstract available
Letter: Efficacy of Intravesical Nadofaragene Firadenovec for Patients With
Bacillus Calmette-Guerin-Unresponsive Nonmuscle Invasive Bladder Cancer: 5-Year
Follow-Up From a Phase 3 Trial.
J Urol. 2024 Jun 19:101097JU0000000000004097. doi: 10.1097/JU.0000000000004097.
PubMed
Nivolumab + Ipilimumab as Immunotherapeutic Boost in Metastatic Urothelial
Carcinoma: A Nonrandomized Clinical Trial.
JAMA Oncol. 2024;10:755-764.
PubMed
Abstract available
Topographic modification of the extracellular matrix precedes the onset of
bladder cancer.
Matrix Biol Plus. 2024;23:100154.
PubMed
Abstract available
Enfortumab vedotin and pembrolizumab combination as a relevant game changer in
urothelial carcinoma: What is left behind?
Med. 2024;5:490-492.
PubMed
Abstract available
In brief: Anktiva for bladder cancer.
Med Lett Drugs Ther. 2024;66:e105-e106.
PubMed
Targeting Chemoresistance in Advanced Bladder Cancers with a Novel Adjuvant
Strategy.
Mol Cancer Ther. 2024 Jun 21:OF1-OF15. doi: 10.1158/1535-7163.MCT-23-0806.
PubMed
Abstract available
Ambient air pollution and urological cancer risk: A systematic review and
meta-analysis of epidemiological evidence.
Nat Commun. 2024;15:5116.
PubMed
Abstract available
Author Correction: Oncolytic adenoviral therapy plus pembrolizumab in
BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial.
Nat Med. 2024 Jun 18. doi: 10.1038/s41591-024-03137.
PubMed
Association of Pro-Inflammatory Diet, Smoking, and Alcohol Consumption with
Bladder Cancer: Evidence from Case-Control and NHANES Studies from 1999 to 2020.
Nutrients. 2024;16:1793.
PubMed
Abstract available
Stereotactic body radiation therapy is beneficial for a subgroup of patients with
urothelial cancer and solitary metastatic disease: a single institution
real-world experience.
Radiat Oncol. 2024;19:74.
PubMed
Abstract available
Prophylactic surgical mesh placement as a prevention of parastomal hernia in open
radical cystectomy with ileal conduit diversion - pilot study.
Rozhl Chir. 2024;103:91-95.
PubMed
Abstract available
Comparison of tissue biomarkers between non-schistosoma and
schistosoma-associated urothelial carcinoma.
Tissue Cell. 2024;88:102416.
PubMed
Abstract available
Integrated bioinformatics investigation of adenylyl cyclase family co-expression
network in bladder cancer followed by preliminary validation of member 2 (ADCY2)
in tumorigenesis and prognosis.
Transl Cancer Res. 2024;13:2222-2237.
PubMed
Abstract available
The Potential Role of Urinary Microbiota in Bladder Carcinogenesis: A Systematic
Review.
Urol J. 2024;21:208-220.
PubMed
Abstract available
Extra-peritoneal vs. Trans-peritoneal Radical Cystectomy pros and cons.
Urol J. 2024;21:271.
PubMed
Abstract available
Multidisciplinary management of sexual and gender minorities with bladder cancer.
Urol Oncol. 2024 Jun 15:S1078-1439(24)00496.
PubMed
Abstract available
Impact of pathologic re-review on grade, clinical stage, and risk stratification
for patients with nonmuscle invasive bladder cancer.
Urol Oncol. 2024 Jun 15:S1078-1439(24)00494.
PubMed
Abstract available
CTLA4 genetic variants associated with urothelial bladder cancer susceptibility.
Urol Oncol. 2024 Jun 14:S1078-1439(24)00490.
PubMed
Abstract available
Is Stent-Free Ureteroenteric Anastomosis Associated With Lower Ureteroenteric
Strictures After Robot-Assisted Radical Cystectomy and Ileal Conduit?
Urol Pract. 2024;11:753-759.
PubMed
Abstract available
Establishing an Intravesical Doublet Chemotherapy Clinic for Nonmuscle-Invasive
Bladder Cancer Patients.
Urol Pract. 2024;11:613-623.
PubMed
Abstract available
[Exploration of the clinical transformation application of the artificial
intelligence diagnosis system for bladder cancer based on cystoscopy].
Zhonghua Yi Xue Za Zhi. 2024;104:2260-2262.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
